PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma / Warmington, E; Smith, G; Chortis, V; Liang, R; Lippert, J; Steinhauer, S; Landwehr, Ls; Hantel, C; Kiseljak-Vassiliades, K; Wierman, Me; Altieri, B; Foster, Pa; Ronchi, Cl. - In: ENDOCRINE CONNECTIONS. - ISSN 2049-3614. - (2023). [10.1530/EC-23-0403]

PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma

Altieri B;
2023-01-01

2023
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma / Warmington, E; Smith, G; Chortis, V; Liang, R; Lippert, J; Steinhauer, S; Landwehr, Ls; Hantel, C; Kiseljak-Vassiliades, K; Wierman, Me; Altieri, B; Foster, Pa; Ronchi, Cl. - In: ENDOCRINE CONNECTIONS. - ISSN 2049-3614. - (2023). [10.1530/EC-23-0403]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/3019259
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact